(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202503 | 202403 | % Var | 202503 | 202403 | % Var | 202503 | 202403 | % Var | |
| Sales | 71857.40 | 56391.40 | 27.43 | 230033.30 | 202751.70 | 13.46 | 230033.30 | 202751.70 | 13.46 |
| Other Income | 3638.10 | 1188.80 | 206.03 | 6239.70 | 4657.60 | 33.97 | 6239.70 | 4657.60 | 33.97 |
| PBIDT | 31214.60 | 20124.10 | 55.11 | 71620.50 | 60533.70 | 18.32 | 71620.50 | 60533.70 | 18.32 |
| Interest | 2174.20 | 2175.90 | -0.08 | 8932.10 | 7840.80 | 13.92 | 8932.10 | 7840.80 | 13.92 |
| PBDT | 29040.40 | 17948.20 | 61.80 | 62688.40 | 50502.70 | 24.13 | 62688.40 | 50502.70 | 24.13 |
| Depreciation | 2919.60 | 3930.40 | -25.72 | 12382.70 | 16006.20 | -22.64 | 12382.70 | 16006.20 | -22.64 |
| PBT | 26120.80 | 14017.80 | 86.34 | 50305.70 | 34496.50 | 45.83 | 50305.70 | 34496.50 | 45.83 |
| TAX | 6116.20 | 5341.80 | 14.50 | 7479.50 | 5914.70 | 26.46 | 7479.50 | 5914.70 | 26.46 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 20004.60 | 8676.00 | 130.57 | 42826.20 | 28581.80 | 49.84 | 42826.20 | 28581.80 | 49.84 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 43.44 | 35.69 | 21.73 | 31.13 | 29.86 | 4.28 | 31.13 | 29.86 | 4.28 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1673.45 |
| Dr. Reddys Lab | 1235.10 |
| Cipla | 1233.00 |
| Zydus Lifesciences | 939.95 |
| Lupin | 2330.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: